HCSC(SH:600378) Zheng Quan Zhi Xing·2025-08-29 18:14Core Viewpoint - The company is undergoing a restructuring process by merging its wholly-owned subsidiaries to enhance operational efficiency and optimize its fluorochemical business structure [2][7]. Group 1: Merger Details - The company’s wholly-owned subsidiary, Hunan Zhonglan New Materials Technology Co., Ltd., will absorb another wholly-owned subsidiary, Chenzhou Zhonghua Fluorine Source New Materials Co., Ltd. [2][7] - After the merger, Hunan Zhonglan will inherit all assets, debts, and rights of Chenzhou Fluorine Source, which will be deregistered [2][3]. Group 2: Fundraising and Investment Projects - The company raised a total of RMB 4,499,999,977.60 through the issuance of 181,451,612 shares at RMB 24.80 per share, with a net amount of RMB 4,496,949,561.34 after deducting issuance costs [3][4]. - The fundraising will be used for projects including the expansion of a 3,000 tons/year CTFE and 10,000 tons/year R113a co-production project, with the implementation subject changing from Chenzhou Fluorine Source to Hunan Zhonglan [6][7]. Group 3: Approval Process - The board of directors and the supervisory board approved the merger and the change of the investment project implementation subject during meetings held on August 28, 2025 [8][10]. - The independent financial advisor, CITIC Securities, confirmed that the merger and project changes complied with relevant regulations and did not alter the intended use of the raised funds [9][10].